GlaxoSmithKline (GSK) is a global pharmaceutical company with a diversified portfolio of biologics, small molecules and consumer healthcare products. In Oncology GSK’s pipeline is focused on immuno-oncology, cell therapy, cancer epigenetics and synthetic lethality. The company was formed in 2000 as a result of merger between GlaxoWellcome plc and SmithKline Beecham.
[stock_market_widget type=”comparison” template=”basic2″ color=”#5679FF” assets=”GSK,AZN,SAN.PA,GILD” fields=”name,change_abs,change_pct,volume,dividend_yield,eps,pe_ratio,shares_outstanding,market_cap,chart” links=”{‘GSK’:{},’AZN’:{},’SAN.PA’:{},’GILD’:{}}” api=”yf” chart_range=”1y” chart_interval=”1d”]
Stock Performance of GlaxoSmithKline plc. Vs Global Peers
Page 3 of 3
